XTX501 in Patients With Metastatic Non-Small Cell Lung Cancer and Advanced Solid Tumors

NCT07688577 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic NSCLC - Non-Small Cell Lung Cancer
Advanced Solid Tumor

Interventions

DRUG: XTX501

Sponsor

Xilio Development, Inc.